Abbvie Inc.

ABBV·NYSE·$213.09Share Price as of 11/2·$376BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/03/26 10-QQ1 ended 03/31/2605/08/26 10-KFY 202502/20/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/04/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report10/15/26 8-KCurrent report10/05/26 8-KCurrent report09/03/26 8-KCurrent report08/18/26

Prospectuses and Registrations

424B5Prospectus supplement08/06/26 FWPFree writing prospectus08/05/26 424B5Prospectus supplement08/04/26 424B5Prospectus supplement02/26/26 FWPFree writing prospectus02/26/26

Proxies

DEF 14ADefinitive proxy03/23/26 DEFA14AAdditional proxy materials03/23/26 PRE 14APreliminary proxy03/09/26 DEF 14ADefinitive proxy03/24/25 DEFA14AAdditional proxy materials03/24/25

Ownership

Form 3Initial insider ownership10/23/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction08/18/26 144Proposed sale of securities08/14/26

Other

11-KEmployee stock purchase plan report06/24/26 SDConflict Minerals disclosure06/01/26 ARSAnnual report to shareholders03/23/26 11-KEmployee stock purchase plan report06/13/25 SDConflict Minerals disclosure05/30/25